ACADIA Pharmaceuticals
ACAD
#3223
Rank
NZ$7.83 B
Marketcap
NZ$46.33
Share price
-2.48%
Change (1 day)
44.20%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Total assets

Total assets on the balance sheet as of September 2025 : NZ$2.30 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's total assets are NZ$2.30 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

ACADIA Pharmaceuticals - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2024-12-31NZ$2.10 B77.83%
2023-12-31NZ$1.18 B27.92%
2022-12-31NZ$0.92 B-9.68%
2021-12-31NZ$1.02 B-5.5%
2020-12-31NZ$1.08 B-6.73%
2019-12-31NZ$1.16 B44.4%
2018-12-31NZ$0.80 B48.75%
2017-12-31NZ$0.54 B-33.17%
2016-12-31NZ$0.81 B149.87%
2015-12-31NZ$0.32 B-21.95%
2014-12-31NZ$0.41 B80.49%
2013-12-31NZ$0.23 B74.34%
2012-12-31NZ$0.13 B220.8%
2011-12-31NZ$41.14 M-17.32%
2010-12-31NZ$49.76 M-27.24%
2009-12-31NZ$68.39 M-38.63%
2008-12-31NZ$0.11 B-36.57%
2007-12-31NZ$0.17 B38.23%
2006-12-31NZ$0.12 B38.99%
2005-12-31NZ$91.44 M61.66%
2004-12-31NZ$56.56 M16.03%
2003-12-31NZ$48.75 M59.24%
2002-12-31NZ$30.61 M-42.1%
2001-12-31NZ$52.88 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Vanda Pharmaceuticals
VNDA
NZ$1.04 B-54.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$361.39 B 15,584.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$198.99 B 8,536.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$333.84 B 14,389.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$167.75 B 7,180.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA